[Efficacy and safety studies review of Teraligen usage in psychiatric practice and general medicine].
A A SmilovichS N GoncharenkoPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
According to the authors, the main effect of the «small» neuroleptic/antipsychotic Alimemazine (Teraligen ) is primarily aimed at pathological anxiety and affective instability. Its use is possible in various age groups, as it has a fairly high safety. In addition, like other «small» neuroleptics/antipsychotics with a predominantly sedative effect, the drug can be used to correct neuroleptics-prolongs side effects with dominant manifestations in the form of anxiety, irritability and insomnia.